The progression rate of spinocerebellar ataxia type 3 varies with disease stage

BACKGROUND: In polyglutamine (polyQ) diseases, the identification of modifiers and the construction of prediction model for progression facilitate genetic counseling, clinical management and therapeutic interventions. METHODS: Data were derived from the longest longitudinal study, with 642 examinati...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Linliu, Peng, Yun, Chen, Zhao, Wang, Chunrong, Long, Zhe, Peng, Huirong, Shi, Yuting, Shen, Lu, Xia, Kun, Leotti, Vanessa B., Jardim, Laura Bannach, Tang, Beisha, Qiu, Rong, Jiang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107762/
https://www.ncbi.nlm.nih.gov/pubmed/35568848
http://dx.doi.org/10.1186/s12967-022-03428-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107762/
https://www.ncbi.nlm.nih.gov/pubmed/35568848
http://dx.doi.org/10.1186/s12967-022-03428-1

Ejemplares similares